Search by Drug Name or NDC
NDC 00781-3269-95 Ephedrine Sulfate 50 mg/mL Details
Ephedrine Sulfate 50 mg/mL
Ephedrine Sulfate is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sandoz Inc. The primary component is EPHEDRINE SULFATE.
Product Information
| NDC | 00781-3269 |
|---|---|
| Product ID | 0781-3269_107cfcd6-4c40-404b-8483-7b08c9020c6a |
| Associated GPIs | 38000030102015 |
| GCN Sequence Number | 076091 |
| GCN Sequence Number Description | ephedrine sulfate VIAL 50MG/ML(1) INTRAVEN |
| HIC3 | J5E |
| HIC3 Description | SYMPATHOMIMETIC AGENTS |
| GCN | 41364 |
| HICL Sequence Number | 002084 |
| HICL Sequence Number Description | EPHEDRINE SULFATE |
| Brand/Generic | Generic |
| Proprietary Name | Ephedrine Sulfate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Ephedrine Sulfate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 50 |
| Active Ingredient Units | mg/mL |
| Substance Name | EPHEDRINE SULFATE |
| Labeler Name | Sandoz Inc |
| Pharmaceutical Class | Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Increased Norepinephrine Activity [PE], Norepinephrine Releasing Agent [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA209784 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00781-3269-95 (00781326995)
| NDC Package Code | 0781-3269-95 |
|---|---|
| Billing NDC | 00781326995 |
| Package | 10 VIAL, SINGLE-DOSE in 1 CARTON (0781-3269-95) / 1 mL in 1 VIAL, SINGLE-DOSE (0781-3269-71) |
| Marketing Start Date | 2017-10-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |